A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors
Bleehen, NM, Girling, DJ, Machin, D, Stephens, RJVolume:
68
Year:
1993
Language:
english
Pages:
7
DOI:
10.1038/bjc.1993.496
File:
PDF, 1.30 MB
english, 1993